Earnings History Data for Morphic (MORF) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Morphic

Morphic Holding Inc. is a biopharmaceutical company. It focuses on the discovery and development of oral small-molecule integrin therapeutics for autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer. Morphic Holding Inc. is based in Waltham, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
25-07-2024	PM		MORF	Morphic	2,832	-1.15	-0.96	0.00		56.60	0.05 (0.09%)	0.0	0.0 (0.00%)	19.34 - 62.08	1,291,489	3,080,000	0

25-04-2024	PM		MORF	Morphic	1,439	-0.91	-0.96	0.00	Morphic GAAP EPS of -$0.91 [4/25/2024 7:51 AM]	27.96	0.27 (0.98%)	0.0	0.0 (0.00%)	19.34 - 63.08	651,284	420,000	0
Morphic GAAP EPS of -$0.91 [4/25/2024 7:51 AM]
03-11-2023	PM		MORF	Morphic	961.00	-0.73	-0.98	0.00	Morphic GAAP EPS of -$0.73 beats by $0.22 [11/3/2023 7:14 AM]	22.60	1.74 (8.34%)	0.0	0.0 (0.00%)	19.34 - 63.08	631,472	580,000	0
Morphic GAAP EPS of -$0.73 beats by $0.22 [11/3/2023 7:14 AM]
25-04-2023	PM	8:00 AM ET (Apr 25)	MORF	Morphic	1,772	-0.90	-0.85	0.00	Morphic GAAP EPS of -$0.90 beats by $1.71, revenue of $0.5M misses by $1.66M [4/25/2023 8:56 AM]	46.61	3.08 (7.08%)	54.85	11.32 (26.01%)	19.23 - 54.97	5,241,677	390,000	734,581
Morphic jumps 38% as lead asset meets key goal in mid-stage trial [4/25/2023 7:35 AM] Morphic GAAP EPS of -$0.90 beats by $1.71, revenue of $0.5M misses by $1.66M [4/25/2023 8:56 AM] Morphic Holding down 10% despite bottom line earnings beat [4/25/2023 1:24 PM]
02-11-2022	PM	8:00 AM ET (Nov 2)	MORF	Morphic	1,078	-0.78	-0.80	0.00	Morphic GAAP EPS of -$0.78 beats by $0.05, revenue of $2.05M misses by $1.05M [11/2/2022 8:22 AM]	28.20	-1.26 (-4.29%)	29.04	-0.43 (-1.46%)	19.23 - 68.75	499,731	0	1,601
Morphic GAAP EPS of -$0.78 beats by $0.05, revenue of $2.05M misses by $1.05M [11/2/2022 8:22 AM] Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2022 [Nov-02-22 08:00AM]
04-05-2022	PM	After the close (May 4)	MORF	Morphic	1,251	-0.85	-0.71	0.00	Morphic GAAP EPS of -$0.85 misses by $0.04, revenue of $2.38M misses by $0.84M [5/4/2022 8:12 AM]	34.57	1.41 (4.25%)	32.70	-0.46 (-1.39%)	28.53 - 68.75	276,115	600,000	1,176
Morphic GAAP EPS of -$0.85 misses by $0.04, revenue of $2.38M misses by $0.84M [5/4/2022 8:12 AM] Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2022 [May-04-22 08:00AM] Morphic Holding, Inc. (MORF) Reports Q1 Loss, Misses Revenue Estimates [May-04-22 09:15AM]
24-02-2022	PM	Before the open (Feb 24)	MORF	Morphic	1,532	-0.57	-0.71	0.00	Morphic GAAP EPS of -$2.67 misses by $0.09, revenue of $19.79M misses by $2.77M [2/24/2022 7:56 AM]	38.55	-1.06 (-2.68%)	0.0	0.0 (0.00%)	0.0 - 0.0	103,405	0	0
Morphic GAAP EPS of -$2.67 misses by $0.09, revenue of $19.79M misses by $2.77M [2/24/2022 7:56 AM] Morphic Announces Corporate Highlights and Financial Results for the Full Year 2021 [Feb-24-22 07:30AM]
04-11-2021	AH	After the close (Nov 4)	MORF	Morphic	2,311	-0.69	-0.76	0.00	Morphic EPS beats by $0.07, misses on revenue [11/4/2021 5:45 PM]	63.00	-2.72 (-4.14%)	65.00	-0.72 (-1.10%)	25.72 - 93.00	219,578	110,000	175
Morphic EPS beats by $0.07, misses on revenue [11/4/2021 5:45 PM] Morphic Announces Corporate Highlights and Third Quarter 2021 Financial Results [Nov-04-21 04:05PM] CFO And COO Of Morphic Holding Trades $510K In Company Stock [Nov-04-21 11:19AM] Morphic Holding, Inc. (MORF) Reports Q3 Loss, Lags Revenue Estimates [Nov-04-21 06:35PM]
04-08-2021	PM	8:00 AM ET (Aug 4)	MORF	Morphic Holding, Inc.	2,100	-0.77	-0.55	0.00	Morphic EPS misses by $0.22, misses on revenue [8/4/2021 7:31 AM]	55.08	1.47 (2.74%)	55.08	0.0 (0.00%)	22.69 - 93.00	490,337	120,000	1,189
Morphic EPS misses by $0.22, misses on revenue [8/4/2021 7:31 AM] Morphic Announces Corporate Highlights and Second Quarter 2021 Financial Results [Aug-04-21 07:00AM] Morphic Holding, Inc. (MORF) Reports Q2 Loss, Misses Revenue Estimates [Aug-04-21 09:05AM]
29-04-2021	PM		MORF	Morphic Holding, Inc.	1,800	-0.63	-0.59	0.00	Morphic EPS misses by $0.09, misses on revenue [4/29/2021 9:00 AM]	54.57	-1.37 (-2.45%)	54.57	0.0 (0.00%)	12.25 - 93.00	83,975	100,000	217
Morphic EPS misses by $0.09, misses on revenue [4/29/2021 9:00 AM] Morphic Announces Corporate Highlights and First Quarter 2021 Financial Results [Apr-29-21 08:00AM] Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors [Apr-28-21 04:01PM] Earnings Preview: Morphic Holding, Inc. (MORF) Q1 Earnings Expected to Decline [Apr-28-21 12:33PM] Morphic Holding, Inc. (MORF) Reports Q1 Loss, Misses Revenue Estimates [Apr-29-21 09:55AM]
01-03-2021	PM	7:00 AM ET (Mar 1)	MORF	Morphic Holding, Inc.	1,130	-0.57	-0.37	-0.66	Morphic EPS misses by $0.11, misses on revenue [3/1/2021 6:59 AM]	84.87	48.71 (134.71%)	44.24	8.08 (22.35%)	9.90 - 93.00	12,573,940	90,708	239,138
Morphic EPS misses by $0.11, misses on revenue [3/1/2021 6:59 AM] Morphic reports positive interim results in early-stage trial for inflammatory bowel disease [3/1/2021 1:07 PM] Morphic price target raised at Wells Fargo on positive data in inflammatory bowel disease [3/1/2021 1:46 PM] Morphic picks a new bull at BMO after positive data for inflammatory bowel disease [3/1/2021 5:15 PM] Morphic Therapeutic proposes $200M capital raise [3/1/2021 4:39 PM] Morphic Holding, Inc. (MORF) Reports Q4 Loss, Misses Revenue Estimates [Mar-01-21 08:15AM] Morphic Reports Positive Interim Results from Single Ascending Dose Phase 1 Clinical Trial of MORF-057 [Mar-01-21 07:00AM]
09-11-2020	PM		MORF	Morphic Holding, Inc.	825.31	0.17	-0.46	-0.30	Morphic EPS beats by $0.71, beats on revenue [11/9/2020 7:17 AM]	29.70	1.60 (5.71%)	28.09	0.0 (0.00%)	9.90 - 31.00	89,497	81,815	112

10-08-2020	PM		MORF	Morphic Holding, Inc.	749.93	-0.52	-0.60	-4.73	Morphic EPS beats by $0.04, beats on revenue [8/10/2020 7:11 AM]	28.88	1.07 (3.85%)	27.81	0.0 (0.00%)	9.90 - 30.54	20,614	52,395	324